Creatine and Creatinine Metabolism - Physiological Reviews

July 2000 CREATINE AND CREATININE METABOLISM 1207
and in Alzheimer disease. Proc Natl Acad Sci USA 88: 10540–
10543, 1991.
909. SMITH CD, LANDRUM W, CARNEY JM, LANDFIELD PW, AND
AVISON MJ. Brain creatine kinase with aging in F-344 rats: analysis
by saturation transfer magnetic resonance spectroscopy.
Neurobiol Aging 18: 617–622, 1997.
910. SMITH CD, PETTIGREW LC, AVISON MJ, KIRSCH JE, TINKHT-
MAN AJ, SCHMITT FA, WERMELING DP, WEKSTEIN DR, AND
MARKESBERRY WR. Frontal lobe phosphorus metabolism and
neuropsychological function in aging and in Alzheimer’s disease.
Ann Neurol 38: 194–201, 1995.
911. SMITH JC, STEPHENS DP, HALL EL, JACKSON AW, AND EAR-
NEST CP. Effect of oral creatine ingestion on parameters of the
work rate-time relationship and time to exhaustion in high-intensity
cycling. Eur J Appl Physiol 77: 360–365, 1998.
912. SMITH MA, HIRAI K, HSIAO K, PAPPOLLA MA, HARRIS PLR,
SIEDLAK SL, TABATON M, AND PERRY G. Amyloid-� deposition
in Alzheimer transgenic mice is associated with oxidative stress.
J Neurochem 70: 2212–2215, 1998.
913. SMITH SA, MONTAIN SJ, MATOTT RP, ZIENTARA GP, JOLESZ
FA, AND FIELDING RA. Creatine supplementation and age influence
muscle metabolism during exercise. J Appl Physiol 85:
1349–1356, 1998.
914. SMITH SH, KRAMER MF, REIS I, BISHOP SP, AND INGWALL JS.
Regional changes in creatine kinase and myocyte size in hypertensive
and nonhypertensive cardiac hypertrophy. Circ Res 67:
1334–1344, 1990.
915. SMITH TS AND BENNETT JP. Mitochondrial toxins in models of
neurodegenerative diseases. I. In vivo brain hydroxyl radical production
during systemic MPTP treatment or following microdialysis
infusion of methylpyridinium or azide ions. Brain Res 765:
183–188, 1997.
916. SMOLENSKI RT, JAYAKUMAR J, SEYMOUR A-ML, AND YACOUB
MH. Energy metabolism and mechanical recovery after cardioplegia
in moderately hypertrophied rats. Mol Cell Biochem 180: 137–
143, 1998.
917. SNOSWELL AM AND XUE G-P. Methyl group metabolism in sheep.
Comp Biochem Physiol B Biochem 88: 383–394, 1987.
918. SNOW RJ, MCKENNA MJ, SELIG SE, KEMP J, STATHIS CG, AND
ZHAO S. Effect of creatine supplementation on sprint exercise
performance and muscle metabolism. J Appl Physiol 84: 1667–
1673, 1998.
919. SNYDERWINE EG. Some perspectives on the nutritional aspects
of breast cancer research. Food-derived heterocyclic amines as
etiologic agents in human mammary cancer. Cancer 74: 1070–
1077, 1994.
920. SNYDERWINE EG, SCHUT HAJ, ADAMSON RH, THORGEIRS-
SON UP, AND THORGEIRSSON SS. Metabolic activation and genotoxicity
of heterocyclic arylamines. Cancer Res 52 Suppl: 2099s–
2102s, 1992.
921. SOBOLL S, CONRAD A, EISTERT A, HERICK K, AND KRÄMER R.
Uptake of creatine phosphate into heart mitochondria: a leak in
the creatine shuttle. Biochim Biophys Acta 1320: 27–33, 1997.
922. SOLOMON MS, MORGENTHALER P-ML, TURESKY RJ, AND ES-
SIGMANN JM. Mutational and DNA binding specificity of the
carcinogen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline. J Biol
Chem 271: 18368–18374, 1996.
923. SÖMJEN D AND KAYE AM. Stimulation by insulin-like growth
factor-I of creatine kinase activity in skeletal-derived cells and
tissues of male and female rats. J Endocrinol 143: 251–259, 1994.
924. SÖMJEN D, TORDJMAN K, WAISMAN A, MOR G, AMIR-ZALTS-
MAN Y, KOHEN F, AND KAYE AM. Estrogen stimulation of creatine
kinase B specific activity in 3T3L1 adipocytes after their
differentiation in culture: dependence on estrogen receptor. J
Steroid Biochem Mol Biol 62: 401–408, 1997.
925. SÖMJEN D, ZOR U, KAYE AM, HARELL A, AND BINDERMAN I.
Parathyroid hormone induction of creatine kinase activity and
DNA synthesis is mimicked by phospholipase C, diacylglycerol
and phorbol ester. Biochim Biophys Acta 931: 215–223, 1987.
926. SONNTAG O. Die Bestimmung der Creatinin-Konzentration in
Serum und Urin. Kritische Übersicht der Routine-Bestimmungsmethoden.
DG Klin Chem Mitteilungen 22: 235–251, 1991.
927. SORA I, RICHMAN J, SANTORO G, WEI H, WANG Y, VANDERAH
T, HORVATH R, NGUYEN M, WAITE S, ROESKE WR, AND
YAMAMURA HI. The cloning and expression of a human creatine
transporter. Biochem Biophys Res Commun 204: 419–427, 1994.
928. SORENSON RL, STOUT LE, BRELJE TC, VAN PILSUM JF, AND
MCGUIRE DM. Evidence for the role of pancreatic acinar cells in
the production of ornithine and guanidinoacetic acid by L-arginine:glycine
amidinotransferase. Pancreas 10: 389–394, 1995.
929. SORRENTINO R AND PINTO A. Effect of methylguanidine on rat
blood pressure: role of endothelial nitric oxide synthase. Br J
Pharmacol 115: 510–514, 1995.
930. SORRENTINO R AND PINTO A. The increase in blood pressure
induced by inhibition of nitric oxide synthase in anesthetized
Wistar rats is inversely related to basal blood pressure value.
J Cardiovasc Pharmacol 29: 599–604, 1997.
931. SORRENTINO R, SAUTEBIN L, AND PINTO A. Effect of methylguanidine,
guanidine and structurally related compounds on constitutive
and inducible nitric oxide synthase activity. Life Sci 61:
1283–1291, 1997.
932. SPENCER K. Analytical reviews in clinical biochemistry: the estimation
of creatinine. Ann Clin Biochem 23: 1–25, 1986.
933. SPINALE FG, SCHULTE BA, AND CRAWFORD FA. Demonstration
of early ischemic injury in porcine right ventricular myocardium.
Am J Pathol 134: 693–704, 1989.
934. SPINGARN NE, SLOCUM LA, AND WEISBURGER JH. Formation
of mutagens in cooked foods. II. Foods with high starch content.
Cancer Lett 9: 7–12, 1980.
935. STACHOWIAK O, DOLDER M, WALLIMANN T, AND RICHTER C.
Mitochondrial creatine kinase is a prime target of peroxynitriteinduced
modification and inactivation. J Biol Chem 273: 16694–
16699, 1998.
936. STADHOUDERS AM, JAP PHK, WINKLER H-P, EPPENBERGER
HM, AND WALLIMANN T. Mitochondrial creatine kinase: a major
constituent of pathological inclusions seen in mitochondrial myopathies.
Proc Natl Acad Sci USA 91: 5089–5093, 1994.
937. STAVRIC B, MATULA TI, KLASSEN R, AND DOWNIE RH. Evaluation
of hamburgers and hot dogs for the presence of mutagens.
Food Chem Toxicol 33: 815–820, 1995.
938. STEEGHS K, BENDERS A, OERLEMANS F, DE HAAN A, HEER-
SCHAP A, RUITENBEEK W, JOST C, VAN DEURSEN J, PERRY-
MAN B, PETTE D, BRÜCKWILDER M, KOUDIJS J, JAP P,
VEERKAMP J, AND WIERINGA B. Altered Ca 2� responses in muscles
with combined mitochondrial and cytosolic creatine kinase
deficiencies. Cell 89: 93–103, 1997.
939. STEEGHS K, HEERSCHAP A, DE HAAN A, RUITENBEEK W,
OERLEMANS F, VAN DEURSEN J, PERRYMAN B, PETTE D,
BRÜCKWILDER M, KOUDIJS J, JAP P, AND WIERINGA B. Use of
gene targeting for compromising energy homeostasis in neuromuscular
tissues: the role of sarcomeric mitochondrial creatine
kinase. J Neurosci Methods 71: 29–41, 1997.
940. STEEGHS K, MERKX G, AND WIERINGA B. The ubiquitous mitochondrial
creatine kinase gene maps to a conserved region on
human chromosome 15q15 and mouse chromosome 2 bands F1–
F3. Genomics 24: 193–195, 1994.
941. STEEGHS K, OERLEMANS F, DE HAAN A, HEERSCHAP A,
VERDOODT L, DE BIE M, RUITENBEEK W, BENDERS A, JOST
C, VAN DEURSEN J, TULLSON P, TERJUNG R, JAP P, JACOB W,
PETTE D, AND WIERINGA B. Cytoarchitectural and metabolic
adaptations in muscles with mitochondrial and cytosolic creatine
kinase deficiencies. Mol Cell Biochem 184: 183–194, 1998.
942. STEEGHS K, OERLEMANS F, AND WIERINGA B. Mice deficient in
ubiquitous mitochondrial creatine kinase are viable and fertile.
Biochim Biophys Acta 1230: 130–138, 1995.
943. STEENGE GR, LAMBOURNE J, CASEY A, MACDONALD IA, AND
GREENHAFF PL. Stimulatory effect of insulin on creatine accumulation
in human skeletal muscle. Am J Physiol Endocrinol
Metab 275: E974–E979, 1998.
944. STEINFELD Y, MEIR G, TEMPEL C, NEEMAN M, AND COHN M.
Cyclocreatine toxicity in multicellular tumor spheroids: 31 P NMR
spectroscopy and diffusion NMR microscopy. Proc Soc Magn
Reson Med 12: 257, 1993.
945. STEKOL JA, WEISS S, SMITH P, AND WEISS K. The synthesis of
choline and creatine in rats under various dietary conditions.
J Biol Chem 201: 299–316, 1953.